Sign in

CIK 0000728387

  • Non-accelerated filer
  • Smaller reporting company

Perspective Therapeutics, Inc.

Sign in to watch
Ticker
CATX
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
411458152
Phone
+1 206-676-0900
Business address
2401 ELLIOTT AVENUE, SUITE 320, SEATTLE, WA, 98121
Former names
IsoRay, Inc., Isoray, Inc., CENTURY PARK PICTURES CORP
  1. 4/A Insider Changes in Ownership
  2. 4/A Insider Changes in Ownership
  3. 4 Open-market buy Director bought 6,266 shares at an average $3.64 ($22,814)
  4. 4 Open-market buy Chief Financial Officer bought 12,829 shares at an average $3.82 ($48,974)
  5. 4 Open-market buy CEO bought 26,500 shares at an average $3.79 ($100,468)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Open-market buy Chief Financial Officer bought 1,800 shares at $9.82 ($17,667)
  15. 4 Open-market buy Director bought 4,587 shares at an average $10.90 ($49,990)
  16. 4 Open-market buy CEO bought 100,000 shares at $1.17 ($117,430)
  17. 4/A Insider Changes in Ownership
  18. 4 Open-market buy Director bought 34,246 shares at $1.46 ($49,992)
  19. 4 Open-market buy Chief Financial Officer bought 25,006 shares at an average $1.40 ($35,007)
  20. 4 Open-market buy Director bought 55,000 shares at $1.38 ($75,900)

Page 3 of 17 · 339 filings